Exact Mass: 897.1571

Exact Mass Matches: 897.1571

Found 48 metabolites which its exact mass value is equals to given mass value 897.1571, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cinnamoyl-CoA

4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-{2-[(2-{[(2E)-3-phenylprop-2-enoyl]sulphanyl}ethyl)-C-hydroxycarbonimidoyl]ethyl}butanimidic acid

C30H42N7O17P3S (897.1571)


Cinnamoyl-coa is a member of the class of compounds known as 2-enoyl coas. 2-enoyl coas are organic compounds containing a coenzyme A substructure linked to a 2-enoyl chain. Cinnamoyl-coa is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Cinnamoyl-coa can be found in sorghum, which makes cinnamoyl-coa a potential biomarker for the consumption of this food product. Cinnamoyl-Coenzyme A is an intermediate in the phenylpropanoids metabolic pathway .

   

Citramalyl-CoA

L-Citramalyl-CoA

C26H42N7O20P3S (897.1418)


An acyl-CoA having citramalyl as the S-acyl group.

   

2-Hydroxyglutaryl-CoA

2-Hydroxyglutaryl-CoA

C26H42N7O20P3S (897.1418)


A hydroxyacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 2-hydroxyglutaric acid.

   

beta-methylmalyl-CoA

PubChem CID: 25246206; (Acyl-CoA); [M+H]+;

C26H42N7O20P3S (897.1418)


   

L-Citramalyl-CoA

(2S)-4-({2-[(3-{[(2R)-4-({[({[(2R,4S,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulphanyl)-2-hydroxy-2-methyl-4-oxobutanoic acid

C26H42N7O20P3S (897.1418)


L-Citramalyl-CoA is an intermediate in C5-Branched dibasic acid metabolism. L-Citramalyl-CoA is the 3rd to last step in the synthesis of (R)-Acetoin and is converted from L-Citramalate via the enzyme citramalate CoA-transferase (EC 2.8.3.7). It is then converted to Pyruvate via the enzyme citramalate-CoA lyase (EC 4.1.3.25). [HMDB] L-Citramalyl-CoA is an intermediate in C5-Branched dibasic acid metabolism. L-Citramalyl-CoA is the 3rd to last step in the synthesis of (R)-Acetoin and is converted from L-Citramalate via the enzyme citramalate CoA-transferase (EC 2.8.3.7). It is then converted to Pyruvate via the enzyme citramalate-CoA lyase (EC 4.1.3.25).

   

(3R)-citramalyl-CoA

(3R)-citramalyl-CoA

C26H42N7O20P3S (897.1418)


The (3R)-diastereomer of citramalyl-CoA.

   

(E)-cinnamoyl-CoA

(E)-cinnamoyl-CoA

C30H42N7O17P3S (897.1571)


The (E)-isomer of cinnamoyl-CoA.

   

2-hydroxy-3-methylbutanedioyl-CoA

4-({2-[(3-{[4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulphanyl)-2-hydroxy-3-methyl-4-oxobutanoic acid

C26H42N7O20P3S (897.1418)


2-hydroxy-3-methylbutanedioyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a 2-hydroxy-3-methylbutanedioic acid thioester of coenzyme A. 2-hydroxy-3-methylbutanedioyl-coa is an acyl-CoA with 5 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. 2-hydroxy-3-methylbutanedioyl-coa is therefore classified as a medium chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. 2-hydroxy-3-methylbutanedioyl-coa, being a medium chain acyl-CoA is a substrate for medium chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, 2-hydroxy-3-methylbutanedioyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of 2-hydroxy-3-methylbutanedioyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts 2-hydroxy-3-methylbutanedioyl-CoA into 2-hydroxy-3-methylbutanedioylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, 2-hydroxy-3-methylbutanedioylcarnitine is converted back to 2-hydroxy-3-methylbutanedioyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of 2-hydroxy-3-methylbutanedioyl-CoA occurs in four steps. First, since 2-hydroxy-3-methylbutanedioyl-CoA is a medium chain acyl-CoA it is the substrate for a medium chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of 2-hydroxy-3-methylbutanedioyl-CoA, creating a double bond between the alpha and beta carbons. FAD is the hydrogen acceptor, yielding FADH2. Second, Enoyl-C...

   

(3R)-3,5-dihydroxy-3-methylpentanoyl-CoA

4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-N-[2-({2-[(3,5-dihydroxy-3-methylpentanoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-2-hydroxy-3,3-dimethylbutanimidic acid

C27H46N7O19P3S (897.1782)


(3r)-3,5-dihydroxy-3-methylpentanoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a (3R)-3_5-dihydroxy-3-methylpentanoic acid thioester of coenzyme A. (3r)-3,5-dihydroxy-3-methylpentanoyl-coa is an acyl-CoA with 4 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. (3r)-3,5-dihydroxy-3-methylpentanoyl-coa is therefore classified as a short chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. (3r)-3,5-dihydroxy-3-methylpentanoyl-coa, being a short chain acyl-CoA is a substrate for short chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA into (3R)-3_5-dihydroxy-3-methylpentanoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, (3R)-3_5-dihydroxy-3-methylpentanoylcarnitine is converted back to (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA occurs in four steps. First, since (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA is a short chain acyl-CoA it is the substrate for a short chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of (3R)-3,5-dihydroxy-3-methylpentanoyl-CoA, creating a double bond betw...

   

4-(methylsulfanyl)-2-oxobutanoyl-CoA

{[5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[3-hydroxy-2,2-dimethyl-3-({2-[(2-{[4-(methylsulfanyl)-2-oxobutanoyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid

C26H42N7O18P3S2 (897.1241)


4-(methylsulfanyl)-2-oxobutanoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a 4-(methylsulfanyl)-2-oxobutanoic acid thioester of coenzyme A. 4-(methylsulfanyl)-2-oxobutanoyl-coa is an acyl-CoA with 5 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. 4-(methylsulfanyl)-2-oxobutanoyl-coa is therefore classified as a medium chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. 4-(methylsulfanyl)-2-oxobutanoyl-coa, being a medium chain acyl-CoA is a substrate for medium chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, 4-(methylsulfanyl)-2-oxobutanoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of 4-(methylsulfanyl)-2-oxobutanoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts 4-(methylsulfanyl)-2-oxobutanoyl-CoA into 4-(methylsulfanyl)-2-oxobutanoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, 4-(methylsulfanyl)-2-oxobutanoylcarnitine is converted back to 4-(methylsulfanyl)-2-oxobutanoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of 4-(methylsulfanyl)-2-oxobutanoyl-CoA occurs in four steps. First, since 4-(methylsulfanyl)-2-oxobutanoyl-CoA is a medium chain acyl-CoA it is the substrate for a medium chain acyl-CoA dehydrogenase, which catalyzes dehydrogenation of 4-(methylsulfanyl)-2-oxobutanoyl-CoA, creating a double bond between the alpha and beta carbons. FAD is the hydrogen...

   

(E)-cinnamoyl-CoA

4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-[2-({2-[(3-phenylprop-2-enoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]butanimidic acid

C30H42N7O17P3S (897.1571)


(e)-cinnamoyl-coa is a member of the class of compounds known as 2-enoyl coas. 2-enoyl coas are organic compounds containing a coenzyme A substructure linked to a 2-enoyl chain (e)-cinnamoyl-coa is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). (e)-cinnamoyl-coa can be found in a number of food items such as green bean, radish (variety), oxheart cabbage, and chicory roots, which makes (e)-cinnamoyl-coa a potential biomarker for the consumption of these food products.

   
   

CoA 5:1;O3

3-phosphoadenosine 5-{3-[(3R)-4-({3-[(2-{[(3S)-3-carboxy-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}

C26H42N7O20P3S (897.1418)


   

CoA 9:5

3-phenylacryloyl-CoA;3-phenylacryloyl-coenzyme A;3-phenylprop-2-enoyl-coenzyme A;benzylideneacetyl-CoA;benzylideneacetyl-coenzyme A;beta-phenylacryloyl-CoA;beta-phenylacryloyl-coenzyme A;cinnamoyl-coenzyme A

C30H42N7O17P3S (897.1571)


   

2-Hydroxyglutaryl-1-coenzyme A

2-Hydroxyglutaryl-1-coenzyme A

C26H42N7O20P3S (897.1418)


   

3-Hydroxyglutaryl-coenzyme A

3-Hydroxyglutaryl-coenzyme A

C26H42N7O20P3S (897.1418)


   

3-Hydroxy-3-methyl-4-carboxybutyl-coa

3-Hydroxy-3-methyl-4-carboxybutyl-coa

C27H46N7O19P3S (897.1782)


   

S-Acetyl-3-mercaptopropanoyl-coa

S-Acetyl-3-mercaptopropanoyl-coa

C26H42N7O18P3S2 (897.1241)


   

5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-2-hydroxy-5-oxopentanoic acid

5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-2-hydroxy-5-oxopentanoic acid

C26H42N7O20P3S (897.1418)


   

2-{7-oxabicyclo[4.1.0]hepta-2,4-dien-1-yl}acetyl-CoA

2-{7-oxabicyclo[4.1.0]hepta-2,4-dien-1-yl}acetyl-CoA

C29H38N7O18P3S-4 (897.1207)


   
   

4-hydroxyphenylacetyl-CoA(4-)

4-hydroxyphenylacetyl-CoA(4-)

C29H38N7O18P3S-4 (897.1207)


   

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-[(2E)-2-(3H-oxepin-2-ylidene)acetyl]sulfanylethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-[(2E)-2-(3H-oxepin-2-ylidene)acetyl]sulfanylethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate

C29H38N7O18P3S-4 (897.1207)


   

2-hydroxycyclohepta-1,4,6-triene-1-carboxyl-CoA

2-hydroxycyclohepta-1,4,6-triene-1-carboxyl-CoA

C29H38N7O18P3S-4 (897.1207)


   

(3R)-3,5-dihydroxy-3-methylpentanoyl-CoA

(3R)-3,5-dihydroxy-3-methylpentanoyl-CoA

C27H46N7O19P3S (897.1782)


   

Cinnamoyl-coenzyme A; (Acyl-CoA); [M+H]+

Cinnamoyl-coenzyme A; (Acyl-CoA); [M+H]+

C30H42N7O17P3S (897.1571)


   

2-oxepin-2(3H)-ylideneacetyl-CoA(4-)

2-oxepin-2(3H)-ylideneacetyl-CoA(4-)

C29H38N7O18P3S-4 (897.1207)


   

(3r,5s,9r,21s)-1-[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxy-3-(Phosphonooxy)tetrahydrofuran-2-Yl]-3,5,9,21-Tetrahydroxy-8,8-Dimethyl-10,14,19-Trioxo-2,4,6-Trioxa-18-Thia-11,15-Diaza-3,5-Diphosphatricosan-23-Oic Acid 3,5-Dioxide

(3r,5s,9r,21s)-1-[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxy-3-(Phosphonooxy)tetrahydrofuran-2-Yl]-3,5,9,21-Tetrahydroxy-8,8-Dimethyl-10,14,19-Trioxo-2,4,6-Trioxa-18-Thia-11,15-Diaza-3,5-Diphosphatricosan-23-Oic Acid 3,5-Dioxide

C26H42N7O20P3S (897.1418)


   

mevalonyl-CoA

mevalonyl-CoA

C27H46N7O19P3S (897.1782)


An acyl-CoA resulting from the formal condensation of the thiol group of coenzyme A with the carboxy group of mevalonic acid.

   

coenzyme alpha-F420-3 penta-anion

coenzyme alpha-F420-3 penta-anion

C34H38N6O21P-5 (897.1828)


   
   

Citramalyl-CoA; (Acyl-CoA); [M+H]+

Citramalyl-CoA; (Acyl-CoA); [M+H]+

C26H42N7O20P3S (897.1418)


   

Beta-Hydroxyasparagine-CoA; (Acyl-CoA); [M+H]+

Beta-Hydroxyasparagine-CoA; (Acyl-CoA); [M+H]+

C25H42N9O19P3S (897.153)


   

CID3514895; (Acyl-CoA); [M+H]+

CID3514895; (Acyl-CoA); [M+H]+

C26H42N7O20P3S (897.1418)


   

2-Hydroxyglutaryl-CoA; (Acyl-CoA); [M+H]+

2-Hydroxyglutaryl-CoA; (Acyl-CoA); [M+H]+

C26H42N7O20P3S (897.1418)


   

L-erythro-3-Methylmalyl-CoA; (Acyl-CoA); [M+H]+

L-erythro-3-Methylmalyl-CoA; (Acyl-CoA); [M+H]+

C26H42N7O20P3S (897.1418)


   

PubChem CID: 15983954; (Acyl-CoA); [M+H]+

PubChem CID: 15983954; (Acyl-CoA); [M+H]+

C27H46N7O19P3S (897.1782)


   

PubChem CID: 25246072; (Acyl-CoA); [M+H]+

PubChem CID: 25246072; (Acyl-CoA); [M+H]+

C26H42N7O20P3S (897.1418)


   

2,3-Dihydroxy-Valerianic Acid-CoA; (Acyl-CoA); [M+H]+

2,3-Dihydroxy-Valerianic Acid-CoA; (Acyl-CoA); [M+H]+

C27H46N7O19P3S (897.1782)


   

Cinnamoyl-CoA

(E)-cinnamoyl-CoA

C30H42N7O17P3S (897.1571)


An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of cinnamic acid.

   

(3S)-citramalyl-CoA

(3S)-citramalyl-CoA

C26H42N7O20P3S (897.1418)


The (3S)-diastereomer of citramalyl-CoA.

   

2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA(4-)

2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA(4-)

C29H38N7O18P3S (897.1207)


An acyl-CoA(4-) oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of 2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA; major species at pH 7.3.

   

(R)-2-hydroxyglutaryl-CoA

(R)-2-hydroxyglutaryl-CoA

C26H42N7O20P3S (897.1418)


A hydroxyglutaryl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (R)-2-hydroxyglutaric acid.

   

2-oxepin-2(3H)-ylideneacetyl-CoA(4-)

2-oxepin-2(3H)-ylideneacetyl-CoA(4-)

C29H38N7O18P3S (897.1207)


An acyl-CoA(4-) oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of 2-oxepin-2(3H)-ylideneacetyl-CoA; major species at pH 7.3.

   

L-erythro-3-methylmalyl-CoA

L-erythro-3-methylmalyl-CoA

C26H42N7O20P3S (897.1418)


A hydroxyacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of L-erythro-3-methylmalic acid.

   
   

(2s)-4-[({[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-2-hydroxy-3,3-dimethyl-n-{2-[(2-{[(2e)-3-phenylprop-2-enoyl]sulfanyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}butanimidic acid

(2s)-4-[({[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-2-hydroxy-3,3-dimethyl-n-{2-[(2-{[(2e)-3-phenylprop-2-enoyl]sulfanyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}butanimidic acid

C30H42N7O17P3S (897.1571)


   

(2r)-4-[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-2-hydroxy-3,3-dimethyl-n-[2-({2-[(3-phenylprop-2-enoyl)sulfanyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]butanimidic acid

(2r)-4-[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]-2-hydroxy-3,3-dimethyl-n-[2-({2-[(3-phenylprop-2-enoyl)sulfanyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]butanimidic acid

C30H42N7O17P3S (897.1571)